Goldman Sachs Initiates Coverage On LifeStance Health Gr with Neutral Rating, Announces Price Target of $9

Benzinga Newsdesk www.benzinga.com Neutral 73.7%

Neg 0% Neu 73.7% Pos 0%

Goldman Sachs analyst Scott Fidel initiates coverage on LifeStance Health Gr (NASDAQ:LFST) with a Neutral rating and announces Price Target of $9.